title: Safety requirement for use of inhaled nitric oxide in neonates.
authors.forename: M
authors.initials: M
authors.lastname: Bouchet
authors.forename: M H
authors.initials: MH
authors.lastname: Renaudin
authors.forename: C
authors.initials: C
authors.lastname: Raveau
authors.forename: J C
authors.initials: JC
authors.lastname: Mercier
authors.forename: M
authors.initials: M
authors.lastname: Dehan
authors.forename: V
authors.initials: V
authors.lastname: Zupan
mesh_terms: D006801:Humans; D007231:Infant, Newborn; D009569:Nitric Oxide / Q000008:administration & dosage* / Q000009:adverse effects; D010084:Oxidation-Reduction; D010102:Oxygen Inhalation Therapy / Q000009:adverse effects*; D010547:Persistent Fetal Circulation Syndrome / Q000188:drug therapy*
chemical_list: D009569:Nitric Oxide